SAN RAFAEL, Calif.,
Jan. 28, 2021 /PRNewswire/
-- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced
the Company received the top score of 100 on the Human Rights
Campaign Foundation's 2021 Corporate Equality Index (CEI), the
nation's foremost benchmarking survey and report measuring
corporate policies and practices related to LGBTQ workplace
equality. BioMarin joins the ranks of 767 major U.S.
businesses that also earned top marks this year.
"At BioMarin, we believe that fostering diversity, equity and
inclusion in our workforce helps our mission of delivering
breakthrough therapies for rare disease patients," said
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of
BioMarin. "We are very proud to receive this important
recognition from the Human Rights Campaign Foundation, highlighting
the long-standing commitment of the BioMarin community to advancing
LGBTQ equality within and beyond our Company."
"From the previously unimaginable impact of the COVID-19
pandemic, to a long overdue reckoning with racial injustice, 2020
was an unprecedented year. Yet, many businesses across the
nation stepped up and continued to prioritize and champion LGBTQ
equality," said Alphonso David,
Human Rights Campaign President. "This year has shown us that
tools like the CEI are crucial in the work to increase equity and
inclusion in the workplace, but also that companies must breathe
life into these policies and practices in real and tangible ways.
Thank you to the companies that understand protecting their
LGBTQ employees and consumers from discrimination is not just the
right thing to do—but the best business decision."
The results of the 2021 CEI showcase how 1,142 U.S.-based
companies are promoting LGBTQ-friendly workplace policies in the
U.S. BioMarin is among the 57 percent of these companies with
global operations, helping to advance the cause of LGBTQ inclusion
in its workplaces abroad as well. BioMarin's efforts in
satisfying all of the CEI's criteria earned a 100 percent ranking
and the designation as one of the Best Places to Work for LGBTQ
Equality.
The CEI rates employers providing these crucial protections to
over 18 million U.S. workers and an additional 17 million abroad.
Companies rated in the CEI include Fortune magazine's 500
largest publicly traded businesses, and hundreds of publicly and
privately held mid- to large-sized businesses. BioMarin is one of
27 biopharmaceutical companies listed in the 2021 CEI.
The CEI rates companies on detailed criteria falling under four
central pillars:
- Non-discrimination policies across business entities;
- Equitable benefits for LGBTQ workers and their families;
- Supporting an inclusive culture; and,
- Corporate social responsibility.
The full report is available online at www.hrc.org/cei.
About the Human Rights Campaign Foundation
The Human Rights Campaign Foundation is the educational arm of
America's largest civil rights organization working to achieve
equality for lesbian, gay, bisexual transgender and queer people.
HRC envisions a world where LGBTQ people are embraced as full
members of society at home, at work and in every community.
About BioMarin
BioMarin is a global biotechnology company that develops and
commercializes innovative therapies for serious and
life-threatening rare and ultra-rare genetic diseases. The
Company's portfolio consists of six commercialized products and
multiple clinical and pre-clinical product candidates. For
additional information, please visit www.biomarin.com.
Information on BioMarin's website is not incorporated by reference
into this press release.
BioMarin® is a registered trademark of BioMarin Pharmaceutical
Inc.
Contacts:
|
Investors
|
Media
|
Traci
McCarty
|
Debra
Charlesworth
|
BioMarin
Pharmaceutical Inc.
|
BioMarin
Pharmaceutical Inc.
|
(415)
455-7558
|
(415)
455-7451
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biomarin-earns-top-marks-in-human-rights-campaigns-2021-corporate-equality-index-301217137.html
SOURCE BioMarin Pharmaceutical Inc.